Add like
Add dislike
Add to saved papers

Photothermal Controlled Generation of Alkyl Radical from Organic Nanoparticles for Tumor Treatment.

The therapeutic properties of light are well known for photodynamic or photothermal therapy, which could cause irreversible photodamage to tumor tissues. Although photodynamic therapy (PDT) has been proved in the clinic, the efficacy is not satisfactory because of complicated tumor microenvironments. For example, the hypoxia in solid tumor has a negative effect on the generation of singlet oxygen. In order to address the hypoxia issues in PDT, leveraging alkyl radical is an available option due to the oxygen-independent feature. In this work, a new kind of organic nanoparticles (TPP-NN NPs) from porphyrin and radical initiator is developed. Under near infrared light irradiation, TPP-NN NPs will splitting and release alkyl radical, which could induce the obvious cytotoxicity whether in normal or hypoxia environment. The photothermal controlled generation of alkyl radical could significantly inhibit the growth of cervical cancer, and show the ignorable systemic toxicity. This activatable radical therapy opens up new possibilities for application of PDT in hypoxia condition.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app